CRISTY BROSOWSKE: Open Payments
NPI 1245541051 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 91 payments from 20 companies in 2025. Trend: 2023 $1,498 · 2024 $1,349 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $231 |
| AstraZeneca Pharmaceuticals LP | 5 | $167 |
| ABBVIE INC. | 17 | $164 |
| PFIZER INC. | 9 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $147 |
| Boston Scientific Corporation | 2 | $113 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 7 | $81 |
| Esperion Therapeutics, Inc. | 5 | $78 |
| Novo Nordisk Inc | 4 | $75 |
Products named: CAPLYTA, EVENITY, WATCHMAN FLX, VRAYLAR, AIRSUPRA, LEQVIO, NURTEC ODT, VOQUEZNA.
Industry payments across ND — which companies pay providers there.
